Inspira Technologies OXY B.H.N. (NASDAQ:IINN) Stock Falls 9.7% – Time to Sell?

Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) dropped 9.7% during mid-day trading on Friday. The company traded as low as $1.3701 and last traded at $1.40. Approximately 5,109,308 shares traded hands during trading, an increase of 1,350% from the average daily volume of 352,435 shares. The stock had previously closed at $1.55.

Inspira Technologies OXY B.H.N. Price Performance

The company has a 50-day moving average of $1.05 and a 200-day moving average of $1.10. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.56 and a quick ratio of 1.30.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Inspira Technologies OXY B.H.N. stock. Yorkville Advisors Global LP boosted its stake in shares of Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) by 10.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,977,724 shares of the company’s stock after purchasing an additional 193,880 shares during the quarter. Inspira Technologies OXY B.H.N. comprises approximately 0.5% of Yorkville Advisors Global LP’s investment portfolio, making the stock its 18th biggest position. Yorkville Advisors Global LP owned about 5.50% of Inspira Technologies OXY B.H.N. worth $883,000 as of its most recent SEC filing. 12.72% of the stock is owned by institutional investors.

Inspira Technologies OXY B.H.N. Company Profile

Inspira Technologies OXY B.H.N. Ltd. is a medical technology company developing respiratory-support systems intended to address acute respiratory failure and reduce the need for invasive mechanical ventilation. The company’s work focuses on technologies that support blood oxygenation and carbon dioxide removal for patients requiring critical-care respiratory assistance.

Its principal platform is the INSPIRA ART system, an extracorporeal respiratory-support technology designed to oxygenate blood outside the body and return it to the patient.